Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC. | Front Immunol | 2023 | 38022567 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients. | Cancer Med | 2023 | 38014487 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
| Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters. | Cancers (Basel) | 2023 | 38001632 | PubTator, text mining | PubMed |
| Discovering KYNU as a feature gene in hidradenitis suppurativa. | Int J Immunopathol Pharmacol | 2023 | 37997679 | PubTator, text mining | PubMed |
| Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog. | BioTech (Basel) | 2023 | 37987478 | PubTator, text mining | PubMed |
| SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. | Cell Rep | 2023 | 37980563 | PubTator, text mining | PubMed |
| Predicting lymph node metastasis in colorectal cancer: An analysis of influencing factors to develop a risk model. | World J Gastrointest Surg | 2023 | 37969707 | PubTator, text mining | PubMed |
| Risk factors for aortoesophageal fistula in cT4b esophageal squamous cell carcinoma after definitive radiation therapy. | J Thorac Dis | 2023 | 37969281 | PubTator, text mining | PubMed |
| Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. | Front Immunol | 2023 | 37965307 | PubTator, text mining | PubMed |
| An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. | NPJ Syst Biol Appl | 2023 | 37945567 | PubTator, text mining | PubMed |
| Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. | Heliyon | 2023 | 37916122 | PubTator, text mining | PubMed |
| Recurrent early-stage squamous cell carcinoma cervical cancer presenting with isolated ovary metastasis: a rare case report. | Ann Med Surg (Lond) | 2023 | 37915691 | PubTator, text mining | PubMed |
| Survival outcomes of esophageal cancer patients with recurrence after curative treatments. | BMC Cancer | 2023 | 37915027 | PubTator, text mining | PubMed |
| 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2. | Pharmaceuticals (Basel) | 2023 | 37895957 | PubTator, text mining | PubMed |
| Cultured Mesenchymal Cells from Nasal Turbinate as a Cellular Model of the Neurodevelopmental Component of Schizophrenia Etiology. | Int J Mol Sci | 2023 | 37895019 | PubTator, text mining | PubMed |
| Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37894277 | PubTator, text mining | PubMed |
| Implementation evaluation of a teledermatology virtual clinic at an academic medical center. | Implement Sci Commun | 2023 | 37891695 | PubTator, text mining | PubMed |
| Clear cell carcinoma arising in an ovarian remnant 19 years after oophoerctomy: case report. | BMC Womens Health | 2023 | 37891576 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=8